Tenaya Therapeutics, Inc. TNYA

Full chart Compare
Set alert

Price alert · TNYA

All alert types
0.36 USD 0.00 (-0.19%)

At closeNov 3, 2026, 4:00 PM EST

0.37 +0.01 +2.00%

After hours · Nov 3, 4:00 PM ET

0.351 Day range 0.3778
0.351 52-week range 1.56
YTD
-49.40%
1 year
-74.80%

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 18.50 +5034.6% upside
Target (low)
6.00
Target (mean)
18.50
Target (high)
40.00
Ratings (0m) 9 9 buy · 0 hold · 0 sell
  • Strong buy3
  • Buy6
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 9
  • 1 month ago 9
  • 2 months ago 9
  • 3 months ago 9

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

TNYA analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.315-0.35 – -0.28-0.40+21.3%00.0%8
Next quarter-0.33-0.36 – -0.30-0.40+17.5%00.0%3
Current year-1.33-1.39 – -1.11-1.68+21.1%00.0%8
Next year-1.26-1.42 – -0.91-1.33+5.2%3.29M0.0%7

Upgrades and downgrades

The latest rating changes

TNYA analyst upgrades and downgrades
DateFirmActionFromTo
Dec 18, 2024Chardan CapitalMaintainedBuyBuy
Dec 18, 2024HC Wainwright & Co.ReiteratedBuyBuy
Nov 26, 2024HC Wainwright & Co.ReiteratedBuyBuy
Nov 25, 2024HC Wainwright & Co.ReiteratedBuyBuy
Nov 7, 2024Chardan CapitalMaintainedBuyBuy
Oct 18, 2024Canaccord GenuityMaintainedBuyBuy
Oct 18, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jul 8, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jun 10, 2024William BlairInitiated—Outperform
May 16, 2024Canaccord GenuityMaintainedBuyBuy
May 15, 2024HC Wainwright & Co.ReiteratedBuyBuy
Mar 21, 2024Chardan CapitalReiteratedBuyBuy
Mar 20, 2024Canaccord GenuityMaintainedBuyBuy
Mar 19, 2024HC Wainwright & Co.ReiteratedBuyBuy
Nov 30, 2023Leerink PartnersInitiated—Outperform
Oct 9, 2023HC Wainwright & Co.ReiteratedBuyBuy
Aug 14, 2023Chardan CapitalReiteratedBuyBuy
Aug 11, 2023Canaccord GenuityMaintainedBuyBuy
Aug 10, 2023Morgan StanleyMaintainedOverweightOverweight
Aug 10, 2023HC Wainwright & Co.ReiteratedBuyBuy
May 12, 2023Chardan CapitalMaintainedBuyBuy
May 11, 2023HC Wainwright & Co.ReiteratedBuyBuy
Mar 9, 2023Chardan CapitalMaintained—Buy
Mar 9, 2023HC Wainwright & Co.Maintained—Buy
Jan 24, 2023Morgan StanleyMaintained—Overweight
Nov 11, 2022Chardan CapitalMaintained—Buy
Nov 8, 2022Canaccord GenuityInitiated—Buy
Aug 11, 2022Chardan CapitalMaintained—Buy
Jun 15, 2022HC Wainwright & Co.Initiated—Buy
May 17, 2022Morgan StanleyMaintained—Overweight